{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:54:45Z","timestamp":1772762085139,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"am","delay-in-days":324,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P50NS108676"],"award-info":[{"award-number":["P50NS108676"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.parkreldis.2025.107969","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T16:01:55Z","timestamp":1753113715000},"page":"107969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Stable two-year longitudinal clinical outcomes in LRRK2 G2019S non-manifest carriers in a remote nationwide study"],"prefix":"10.1016","volume":"138","author":[{"given":"William","family":"Barbosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peggy","family":"Auinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saloni","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca Y.","family":"Valdovinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Norcliffe-Kaufmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Rowbotham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy N.","family":"Alcalay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Biglan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Kinel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline M.","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Holloway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Ray","family":"Dorsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8094-4041","authenticated-orcid":false,"given":"Ruth B.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.parkreldis.2025.107969_bib1","first-page":"407","article-title":"Parkinson's progression markers initiative","volume":"22","author":"Siderowf","year":"2023","journal-title":"Assess. heterogeneity among Particip. Parkinson's Prog. Markers Int. Cohort Alpha-Synuclein Seed Amplif.: crosssec. study Lancet Neurol."},{"issue":"7 Suppl 1","key":"10.1016\/j.parkreldis.2025.107969_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0000000000200789","article-title":"Planning for prevention of parkinson disease: now is the time","volume":"99","author":"Crotty","year":"2022","journal-title":"Neurology"},{"issue":"7 Suppl 1","key":"10.1016\/j.parkreldis.2025.107969_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1212\/WNL.0000000000200812","article-title":"Who to enroll in parkinson disease prevention trials? The case for genetically At-Risk cohorts","volume":"99","author":"Niotis","year":"2022","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.parkreldis.2025.107969_bib4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated parkinson's disease: a case-control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2025.107969_bib5","author":"Biogen"},{"issue":"8","key":"10.1016\/j.parkreldis.2025.107969_bib6","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/mds.26614","article-title":"Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease","volume":"31","author":"Marras","year":"2016","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.parkreldis.2025.107969_bib7","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/brain\/awae073","article-title":"Genetic analysis and natural history of Parkinson's disease due to the LRRK2 G2019S variant","volume":"147","author":"Kmiecik","year":"2024","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.parkreldis.2025.107969_bib8","first-page":"140","article-title":"Parkinson's progression marker initiative","volume":"8","author":"Simuni","year":"2022","journal-title":"Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort. NPJ Parkinsons Dis."},{"issue":"3","key":"10.1016\/j.parkreldis.2025.107969_bib9","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3233\/JPD-202019","article-title":"A virtual cohort study of individuals at genetic risk for parkinson's disease: study protocol and design","volume":"10","author":"Schneider","year":"2020","journal-title":"J. Parkinsons Dis."},{"issue":"5","key":"10.1016\/j.parkreldis.2025.107969_bib10","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200008","article-title":"A remote longitudinal observational study of individuals at genetic risk for parkinson disease","volume":"8","author":"Jensen-Roberts","year":"2022","journal-title":"Neurology-Genetics"},{"issue":"4","key":"10.1016\/j.parkreldis.2025.107969_bib11","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3233\/JPD-202163","article-title":"Feasibility, reliability, and value of remote video-based trial visits in parkinson's disease","volume":"10","author":"Tarolli","year":"2020","journal-title":"J. Parkinsons Dis."},{"issue":"12","key":"10.1016\/j.parkreldis.2025.107969_bib12","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal parkinson's disease","volume":"30","author":"Berg","year":"2015","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2025.107969_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/WAD.0000000000000145","article-title":"Reversion from mild cognitive impairment to normal cognition: a meta-analysis","volume":"30","author":"Malek-Ahmadi","year":"2016","journal-title":"Alzheimer Dis. Assoc. Disord."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802025007102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802025007102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:53:45Z","timestamp":1772758425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802025007102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":13,"alternative-id":["S1353802025007102"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107969","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stable two-year longitudinal clinical outcomes in LRRK2 G2019S non-manifest carriers in a remote nationwide study","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107969","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107969"}}